GSP Crop Science reported a 19% increase in net profit for the financial year ended March 31, 2026, reaching ₹898.35 million, driven by higher revenue from operations. The agrochemical company recorded revenue of ₹16,059.06 million for FY26, up from ₹14,086.94 million in the previous year. For the quarter ended March 31, 2026, net profit stood at ₹216.09 million against ₹223 million in the same quarter of the prior year, while revenue from operations was ₹4.3 billion compared to ₹3.28 billion year-on-year.

The Board of Directors, at its meeting held on May 26, 2026, approved the audited standalone and consolidated financial results. M/s. MSKC & Associates LLP, Statutory Auditors, issued an audit report with an unmodified opinion on the results. The board also recommended a final dividend of Re.1.00 per equity share, having a face value of ₹10 each, for FY26. This dividend is subject to the approval of shareholders at the ensuing Annual General Meeting.

Financial Performance

The company's standalone financial results for FY26 show a rise in total income to ₹16,276.08 million from ₹14,260.12 million in the previous year. Total expenses for the year increased to ₹15,042.82 million. Basic earnings per share (EPS) for the year improved to ₹22.88 from ₹19.55 in the prior year. The following table summarises the key annual financial metrics:

On a consolidated basis, net profit for the year attributable to equity holders of the parent was ₹978.95 million, compared to ₹834.40 million in the previous year. Consolidated revenue from operations stood at ₹15,171.06 million for FY26.

Q4 Performance

For the quarter ended March 31, 2026, the company's quarterly performance reflected mixed trends, with revenue growth offset by margin pressure. Q4 EBITDA stood at ₹320 million against ₹365 million in the same quarter of the prior year, while the EBITDA margin contracted to 7.46% from 11.1% year-on-year. The table below presents the key Q4 metrics on a year-on-year basis:

Management Changes and Appointments

The board approved several key managerial appointments effective June 1, 2026. Mr. Shail Jayesh Shah was re-designated from Whole Time Director and Chief Financial Officer to Whole Time Director designated as Executive Director – Strategy and Corporate Affairs. Consequently, he will cease to be the Chief Financial Officer effective May 31, 2026. Mr. Pranav Chitre was appointed as the new Chief Financial Officer (Key Managerial Personnel) of the company. Additionally, the board appointed Mahajan & Aibara LLP as the Internal Auditor and re-appointed M/s. Dalwadi & Associates, Cost Accountants, as the Cost Auditor for the financial year 2026-27.

IPO Proceeds Utilisation

During the year, the company completed its Initial Public Offering (IPO), listing on the NSE and BSE on March 24, 2026. Net proceeds from the fresh issue amounted to ₹2,203.17 million. As of March 31, 2026, the company utilised ₹1,072.64 million of the proceeds, primarily for the repayment of borrowings and general corporate purposes.